Sage Journals: Discover world-class research

Open access

Review article

First published 2018

CDK4/6 inhibition in breast cancer: current practice and future directions

Sonia Pernas, Sara M. Tolaney, Eric P. Winer [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients

Xiaomeng Jia, Kainan Wang, Xueqing Wang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2025

Cardiovascular safety of CDK4/6 inhibitors in advance breast cancer: Assessing risks of QTc prolongation and thrombosis

Alaa Shahbar

Journal of Oncology Pharmacy Practice

Open access

Brief report

First published 2026

Integration of pre‑existing cardiovascular comorbidity into CDK4/6 inhibitor selection for breast cancer

Chanhyun Park, Kiyoung Kim, Nora B. Abifaraj [...]

Therapeutic Advances in Drug Safety

Retricted access

Research article

First published 2023-12

CDK4/6 inhibitors in metastatic breast cancer,a comparison of toxicity and efficacy across agents in a real-world dataset

William Buller, Lalit Pallan, Teresa Chu [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024

Adverse event profiles of CDK4/6 inhibitors: data mining and disproportionality analysis of the FDA adverse event reporting system

Jun Shen, Pingli Luo, Jianmei Xu

Therapeutic Advances in Drug Safety

Open access

Review article

First published 2024

Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer

Sijia Wu, Junnan Xu, Yiwen Ma [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2018

Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper

Nicolò Matteo Luca Battisti, Nienke De Glas, Mina S. Sedrak [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2018

Inhibitors targeting CDK4/6,PARP and PI3K in breast cancer: a review

Siti Muhamad Nur Husna, Hern-Tze Tina Tan, Rohimah Mohamud [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2023

CDK4/6 inhibitors: basics,pros,and major cons in breast cancer treatment with specific regard to cardiotoxicity – a narrative review

Dragica Pavlovic, Danijela Niciforovic, Dragana Papic [...]

Therapeutic Advances in Medical Oncology

Search results